改善肥胖儿科患者合理用药的质量计划。

IF 1.2 Q3 PEDIATRICS
Pediatric quality & safety Pub Date : 2024-06-11 eCollection Date: 2024-05-01 DOI:10.1097/pq9.0000000000000741
Colleen P Cloyd, Danielle Macedone, Jenna Merandi, Shawn Pierson, Maria Sellas Wcislo, Jeffrey Lutmer, Jennifer MacDonald, Onsy Ayad, Lindsay Kalata, R Zachary Thompson
{"title":"改善肥胖儿科患者合理用药的质量计划。","authors":"Colleen P Cloyd, Danielle Macedone, Jenna Merandi, Shawn Pierson, Maria Sellas Wcislo, Jeffrey Lutmer, Jennifer MacDonald, Onsy Ayad, Lindsay Kalata, R Zachary Thompson","doi":"10.1097/pq9.0000000000000741","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Emerging evidence supports the use of alternative dosing weights for medications in patients with obesity. Pediatric obesity presents a particular challenge because most medications are dosed based on patient weight. Additionally, building system-wide pediatric obesity safeguards is difficult due to pediatric obesity definitions of body mass index-percentile-for-age via the Center for Disease Control growth charts. We describe a quality initiative to increase appropriate medication dosing in inpatients with obesity. The specific aim was to increase appropriate dosing for 7 high-risk medications in inpatients with obesity ≥2 years old from 37% to >74% and to sustain for 1 year.</p><p><strong>Methods: </strong>The Institute for Healthcare Improvement model for improvement was used to plan interventions and track outcomes progress. Interventions included a literature review to establish internal dosing guidance, electronic health record (EHR) functionality to identify pediatric patients with obesity, a default selection for medication weight with an opt-out, and obtaining patient heights in the emergency department.</p><p><strong>Results: </strong>Appropriate dosing weight use in medication ordered for patients with obesity increased from 37% to 83.4% and was sustained above the goal of 74% for 12 months.</p><p><strong>Conclusions: </strong>Implementation of EHR-based clinical decision support has increased appropriate evidence-based dosing of medications in pediatric and adult inpatients with obesity. Future studies should investigate the clinical and safety implications of using alternative dosing weights in pediatric patients.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167219/pdf/","citationCount":"0","resultStr":"{\"title\":\"A Quality Initiative to Improve Appropriate Medication Dosing in Pediatric Patients with Obesity.\",\"authors\":\"Colleen P Cloyd, Danielle Macedone, Jenna Merandi, Shawn Pierson, Maria Sellas Wcislo, Jeffrey Lutmer, Jennifer MacDonald, Onsy Ayad, Lindsay Kalata, R Zachary Thompson\",\"doi\":\"10.1097/pq9.0000000000000741\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Emerging evidence supports the use of alternative dosing weights for medications in patients with obesity. Pediatric obesity presents a particular challenge because most medications are dosed based on patient weight. Additionally, building system-wide pediatric obesity safeguards is difficult due to pediatric obesity definitions of body mass index-percentile-for-age via the Center for Disease Control growth charts. We describe a quality initiative to increase appropriate medication dosing in inpatients with obesity. The specific aim was to increase appropriate dosing for 7 high-risk medications in inpatients with obesity ≥2 years old from 37% to >74% and to sustain for 1 year.</p><p><strong>Methods: </strong>The Institute for Healthcare Improvement model for improvement was used to plan interventions and track outcomes progress. Interventions included a literature review to establish internal dosing guidance, electronic health record (EHR) functionality to identify pediatric patients with obesity, a default selection for medication weight with an opt-out, and obtaining patient heights in the emergency department.</p><p><strong>Results: </strong>Appropriate dosing weight use in medication ordered for patients with obesity increased from 37% to 83.4% and was sustained above the goal of 74% for 12 months.</p><p><strong>Conclusions: </strong>Implementation of EHR-based clinical decision support has increased appropriate evidence-based dosing of medications in pediatric and adult inpatients with obesity. Future studies should investigate the clinical and safety implications of using alternative dosing weights in pediatric patients.</p>\",\"PeriodicalId\":74412,\"journal\":{\"name\":\"Pediatric quality & safety\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-06-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167219/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric quality & safety\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/pq9.0000000000000741\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric quality & safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/pq9.0000000000000741","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

摘要

导言:越来越多的证据支持对肥胖症患者使用其他剂量。小儿肥胖症是一个特殊的挑战,因为大多数药物都是根据患者体重来确定剂量的。此外,由于儿科肥胖症的定义是通过疾病控制中心的生长图表得出的体重指数-年龄百分位数,因此很难建立全系统的儿科肥胖症保障措施。我们介绍了一项旨在提高肥胖住院患者合理用药剂量的质量计划。具体目标是将肥胖≥2 岁住院患者的 7 种高风险药物的合理用药率从 37% 提高到 >74%,并持续一年:方法:采用美国医疗保健改进研究所的改进模式来规划干预措施并跟踪结果进展。干预措施包括:文献回顾以建立内部剂量指导、电子健康记录(EHR)功能以识别肥胖儿科患者、默认选择药物重量(可选择退出)以及在急诊科获取患者身高:结果:在肥胖症患者的用药订单中使用适当剂量重量的比例从 37% 提高到 83.4%,并在 12 个月内保持在 74% 以上的目标水平:结论:基于电子病历的临床决策支持的实施提高了肥胖症儿科和成人住院患者的合理循证用药剂量。未来的研究应探讨在儿科患者中使用其他剂量权重的临床和安全性影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Quality Initiative to Improve Appropriate Medication Dosing in Pediatric Patients with Obesity.

Introduction: Emerging evidence supports the use of alternative dosing weights for medications in patients with obesity. Pediatric obesity presents a particular challenge because most medications are dosed based on patient weight. Additionally, building system-wide pediatric obesity safeguards is difficult due to pediatric obesity definitions of body mass index-percentile-for-age via the Center for Disease Control growth charts. We describe a quality initiative to increase appropriate medication dosing in inpatients with obesity. The specific aim was to increase appropriate dosing for 7 high-risk medications in inpatients with obesity ≥2 years old from 37% to >74% and to sustain for 1 year.

Methods: The Institute for Healthcare Improvement model for improvement was used to plan interventions and track outcomes progress. Interventions included a literature review to establish internal dosing guidance, electronic health record (EHR) functionality to identify pediatric patients with obesity, a default selection for medication weight with an opt-out, and obtaining patient heights in the emergency department.

Results: Appropriate dosing weight use in medication ordered for patients with obesity increased from 37% to 83.4% and was sustained above the goal of 74% for 12 months.

Conclusions: Implementation of EHR-based clinical decision support has increased appropriate evidence-based dosing of medications in pediatric and adult inpatients with obesity. Future studies should investigate the clinical and safety implications of using alternative dosing weights in pediatric patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信